Artificial and engineered chromosomes: Developments and prospects for gene therapy

Brenda Grimes, Zoia Larin Monaco

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

At the gene therapy session of the ICCXV Chromosome Conference (2004), recent advances in the construction of engineered chromosomes and de novo human artificial chromosomes were presented. The long-term aims of these studies are to develop vectors as tools for studying genome and chromosome function and for delivering genes into cells for therapeutic applications. There are two primary advantages of chromosome-based vector systems over most conventional vectors for gene delivery. First, the transferred DNA can be stably maintained without the risks associated with insertion, and second, large DNA segments encompassing genes and their regulatory elements can be introduced, leading to more reliable transgene expression. There is clearly a need for safe and effective gene transfer vectors to correct genetic defects. Among the topics discussed at the gene therapy session and the main focus of this review are requirements for de novo human artificial chromosome formation, assembly of chromatin on de novo human artificial chromosomes, advances in vector construction, and chromosome transfer to cells and animals.

Original languageEnglish
Pages (from-to)230-241
Number of pages12
JournalChromosoma
Volume114
Issue number4
DOIs
StatePublished - Sep 2005

Fingerprint

Artificial Chromosomes
Human Artificial Chromosomes
Genetic Therapy
Chromosomes
Genes
Chromatin Assembly and Disassembly
DNA
Regulator Genes
Transgenes
Genome

ASJC Scopus subject areas

  • Genetics

Cite this

Artificial and engineered chromosomes : Developments and prospects for gene therapy. / Grimes, Brenda; Monaco, Zoia Larin.

In: Chromosoma, Vol. 114, No. 4, 09.2005, p. 230-241.

Research output: Contribution to journalArticle

@article{7a6a3a52926a45efbf3fc5910efda5a7,
title = "Artificial and engineered chromosomes: Developments and prospects for gene therapy",
abstract = "At the gene therapy session of the ICCXV Chromosome Conference (2004), recent advances in the construction of engineered chromosomes and de novo human artificial chromosomes were presented. The long-term aims of these studies are to develop vectors as tools for studying genome and chromosome function and for delivering genes into cells for therapeutic applications. There are two primary advantages of chromosome-based vector systems over most conventional vectors for gene delivery. First, the transferred DNA can be stably maintained without the risks associated with insertion, and second, large DNA segments encompassing genes and their regulatory elements can be introduced, leading to more reliable transgene expression. There is clearly a need for safe and effective gene transfer vectors to correct genetic defects. Among the topics discussed at the gene therapy session and the main focus of this review are requirements for de novo human artificial chromosome formation, assembly of chromatin on de novo human artificial chromosomes, advances in vector construction, and chromosome transfer to cells and animals.",
author = "Brenda Grimes and Monaco, {Zoia Larin}",
year = "2005",
month = "9",
doi = "10.1007/s00412-005-0017-5",
language = "English",
volume = "114",
pages = "230--241",
journal = "Chromosoma",
issn = "0009-5915",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "4",

}

TY - JOUR

T1 - Artificial and engineered chromosomes

T2 - Developments and prospects for gene therapy

AU - Grimes, Brenda

AU - Monaco, Zoia Larin

PY - 2005/9

Y1 - 2005/9

N2 - At the gene therapy session of the ICCXV Chromosome Conference (2004), recent advances in the construction of engineered chromosomes and de novo human artificial chromosomes were presented. The long-term aims of these studies are to develop vectors as tools for studying genome and chromosome function and for delivering genes into cells for therapeutic applications. There are two primary advantages of chromosome-based vector systems over most conventional vectors for gene delivery. First, the transferred DNA can be stably maintained without the risks associated with insertion, and second, large DNA segments encompassing genes and their regulatory elements can be introduced, leading to more reliable transgene expression. There is clearly a need for safe and effective gene transfer vectors to correct genetic defects. Among the topics discussed at the gene therapy session and the main focus of this review are requirements for de novo human artificial chromosome formation, assembly of chromatin on de novo human artificial chromosomes, advances in vector construction, and chromosome transfer to cells and animals.

AB - At the gene therapy session of the ICCXV Chromosome Conference (2004), recent advances in the construction of engineered chromosomes and de novo human artificial chromosomes were presented. The long-term aims of these studies are to develop vectors as tools for studying genome and chromosome function and for delivering genes into cells for therapeutic applications. There are two primary advantages of chromosome-based vector systems over most conventional vectors for gene delivery. First, the transferred DNA can be stably maintained without the risks associated with insertion, and second, large DNA segments encompassing genes and their regulatory elements can be introduced, leading to more reliable transgene expression. There is clearly a need for safe and effective gene transfer vectors to correct genetic defects. Among the topics discussed at the gene therapy session and the main focus of this review are requirements for de novo human artificial chromosome formation, assembly of chromatin on de novo human artificial chromosomes, advances in vector construction, and chromosome transfer to cells and animals.

UR - http://www.scopus.com/inward/record.url?scp=27844596238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27844596238&partnerID=8YFLogxK

U2 - 10.1007/s00412-005-0017-5

DO - 10.1007/s00412-005-0017-5

M3 - Article

C2 - 16133351

AN - SCOPUS:27844596238

VL - 114

SP - 230

EP - 241

JO - Chromosoma

JF - Chromosoma

SN - 0009-5915

IS - 4

ER -